Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatosis 1 × Dietary Supplements × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1

Interventions

AZD 6244 17 trametinib 5 Lovastatin 5 Deoxycholic Acid 4 Lasers, Solid-State 3 pirfenidone 2 mirdametinib 2 fludarabine 2 binimetinib 2 Vincristine 2 Vinblastine 2 Specimen Handling 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Everolimus 2 Carboplatin 2 Blood Specimen Collection 2 Biopsy 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 talimogene laherparepvec 1 pomalidomide 1 peginterferon alfa-2b 1 omipalisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01968590 2022-05-25

VitDBoneNF1

University of Utah

Phase 2 Terminated

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡